Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab.

Thanos D. Papakostas,Laurence Shen Lim,T van Zyl,John B. Miller,Bobeck S. Modjtahedi,Christopher M. Andreoli,David M. Wu,Lucy H. Young,Ivana K. Kim,Demetrios G. Vavvas,D. D. Esmaili,Deeba Husain,Dean Eliott,Leo A. Kim

Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab.

2016

Thanos D. Papakostas
Laurence Shen Lim
T van Zyl
John B. Miller
Bobeck S. Modjtahedi
Christopher M. Andreoli
David M. Wu
Lucy H. Young
Ivana K. Kim
Demetrios G. Vavvas
D. D. Esmaili
Deeba Husain
Dean Eliott
Leo A. Kim

Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab

Keywords:

Ranibizumab
Glaucoma
Surgery
Bevacizumab
Ophthalmology
Visual acuity
Macular edema
Neuro-ophthalmology
Central retinal vein occlusion
Medicine
Aflibercept

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations